TY - JOUR
T1 - Nationwide epidemiological survey of chronic pancreatitis in Japan
T2 - introduction and validation of the new Japanese diagnostic criteria 2019
AU - for the Japan Pancreas Society
AU - Masamune, Atsushi
AU - Kikuta, Kazuhiro
AU - Kume, Kiyoshi
AU - Hamada, Shin
AU - Tsuji, Ichiro
AU - Takeyama, Yoshifumi
AU - Shimosegawa, Tooru
AU - Okazaki, Kazuichi
AU - Miura, Shin
AU - Takikawa, Tetsuya
AU - Hongo, Seiji
AU - Nakano, Eriko
AU - Nabeshima, Tatsuhide
AU - Matsumoto, Ryotaro
AU - Tanaka, Yu
AU - Ueno, Masayuki
AU - Mukai, Tsuyoshi
AU - Matsumoto, Masataka
AU - Kudo, Yasushi
AU - Azuma, Shunjiro
AU - Okuwaki, Kosuke
AU - Yamamoto, Satoshi
AU - Inui, Kazuo
AU - Kobashigawa, Kasen
AU - Unno, Jun
AU - Fujimori, Nao
AU - Kitamura, Katsuya
AU - Miyakawa, H. iroyuki
AU - Takahashi, Kuniyuki
AU - Ikeura, Tsukasa
AU - Takenaka, Mamoru
AU - Fukasawa, Mitsuharu
AU - Funayama, Hiroyuki
AU - Mitoro, Akira
AU - Takagi, Tadayuki
AU - Sekine, Masanari
AU - Suwa, Kanetoshi
AU - Sakagami, Junichi
AU - Ishida, Masaharu
AU - Ohtsuka, Masayuki
AU - Kagawa, S. hingo
AU - Muraki, Takashi
AU - Watanabe, Takayuki
AU - Watanabe, Takashi
AU - Yamamoto, Katsunori
AU - Masaka, T. omohiro
AU - Nagahama, Masatsugu
AU - Sato, Ai
AU - Aruga, Yukio
AU - Nakai, Yousuke
N1 - Publisher Copyright:
© 2020, Japanese Society of Gastroenterology.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Objectives: To provide updated clinico-epidemiological information on chronic pancreatitis (CP) in Japan. Methods: We conducted a two-stage nationwide epidemiological survey; the number of CP patients was estimated in the first-stage survey, and their clinical features were examined in the second-stage survey. We surveyed patients with CP who had visited hospitals in 2016 and were diagnosed according to the Japanese diagnostic criteria 2009 (DC2009). Furthermore, we validated the new Japanese diagnostic criteria (DC2019) in patients with early CP diagnosed according to DC2009. Results: The number of patients with definite/probable CP in 2016 was 56,520 (prevalence, 44.5 per 100,000 persons), and that of early CP was 4470 (prevalence, 3.5 per 100,000 persons). We obtained detailed clinical information of 2150 patients with definite/probable CP and 249 patients with early CP. Compared with the early CP cases, the definite/probable CP cases had higher proportions of male (4.8 vs. 1.3), alcohol-related etiology (72.0% vs. 45.8%), smoking history (69.6% vs. 41.0%), diabetes mellitus (42.3% vs. 19.3%), and past history of acute pancreatitis (AP) (50.4% vs. 22.1%). Among the patients with early CP diagnosed according to DC2009, 93 (37.3%) were diagnosed with early CP according to DC2019, but the diagnosis of the remaining 156 (62.7%) patients was downgraded. Alcohol-related etiology, smoking history, early disease onset, and past history of AP were associated with the maintenance of early CP diagnosis in DC2019. Conclusion: We clarified the current status of CP in Japan. Further validation studies are warranted to clarify the diagnostic utility of DC2019.
AB - Objectives: To provide updated clinico-epidemiological information on chronic pancreatitis (CP) in Japan. Methods: We conducted a two-stage nationwide epidemiological survey; the number of CP patients was estimated in the first-stage survey, and their clinical features were examined in the second-stage survey. We surveyed patients with CP who had visited hospitals in 2016 and were diagnosed according to the Japanese diagnostic criteria 2009 (DC2009). Furthermore, we validated the new Japanese diagnostic criteria (DC2019) in patients with early CP diagnosed according to DC2009. Results: The number of patients with definite/probable CP in 2016 was 56,520 (prevalence, 44.5 per 100,000 persons), and that of early CP was 4470 (prevalence, 3.5 per 100,000 persons). We obtained detailed clinical information of 2150 patients with definite/probable CP and 249 patients with early CP. Compared with the early CP cases, the definite/probable CP cases had higher proportions of male (4.8 vs. 1.3), alcohol-related etiology (72.0% vs. 45.8%), smoking history (69.6% vs. 41.0%), diabetes mellitus (42.3% vs. 19.3%), and past history of acute pancreatitis (AP) (50.4% vs. 22.1%). Among the patients with early CP diagnosed according to DC2009, 93 (37.3%) were diagnosed with early CP according to DC2019, but the diagnosis of the remaining 156 (62.7%) patients was downgraded. Alcohol-related etiology, smoking history, early disease onset, and past history of AP were associated with the maintenance of early CP diagnosis in DC2019. Conclusion: We clarified the current status of CP in Japan. Further validation studies are warranted to clarify the diagnostic utility of DC2019.
UR - http://www.scopus.com/inward/record.url?scp=85091894136&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091894136&partnerID=8YFLogxK
U2 - 10.1007/s00535-020-01704-9
DO - 10.1007/s00535-020-01704-9
M3 - Article
C2 - 32676800
AN - SCOPUS:85091894136
SN - 0944-1174
VL - 55
SP - 1062
EP - 1071
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 11
ER -